Sacc, L., Cittadini, A
Hildebrandt W, Sauer R, Bonaterra G, Dugi KA, Edler L, Kinscherf R
It should be pointed out that Griffith [11] originally validated this method in plasma where the artifactual oxidation of GSH is minimal, i.e., tolerable, because the GSH/GSSG ratio in plasma is much lower than in cells (~2 instead of ~400) [3], but this procedure has later been applied broadly to whole blood, red cells or other tissues in which GSH massively exceeds GSSG without proper modification
It improves vessel wall stability and decreases inflammatory infiltration, providing a protective role in heart and vascular injury models
Midyett LK, Rogol AD, Van Meter QL, Frane J, Bright GM
What is the Precision Peptide Genetic Test and how does it help with GLP-1 selection